Non-hemodynamic effects: Repurposing of nonselective beta-blockers in cirrhosis?

被引：5
|
作者：
Yang, Yi [1 ,2 ]
Li, Mingkai [1 ,3 ]
Luo, Jinni [1 ,3 ]
Yu, Hongsheng [1 ,3 ]
Tian, Hong [1 ,3 ]
Wang, Xing [1 ,3 ]
机构：
[1] Sun Yat Sen Univ, Dept Gastroenterol, Affiliated Hosp 3, 600 Tianhe Rd, Guangzhou 510630, Peoples R China
[2] Xizang Minzu Univ, Sch Med, Xianyang, Peoples R China
[3] Guangdong Prov Key Lab Liver Dis Res, Guangzhou, Peoples R China
来源：
PORTAL HYPERTENSION & CIRRHOSIS | 2022年 / 1卷 / 02期
基金：
中国国家自然科学基金;
关键词：
SURVIVAL;
D O I：
10.1002/poh2.22
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：153 / 156
页数：4
相关论文
共 44 条
  • [21] Effects of Beta-Blockers on Melanoma Microenvironment and Disease Survival in Human
    Wrobel, Ludovic Jean
    Gayet-Ageron, Angele
    Le Gal, Frederique-Anne
    CANCERS, 2020, 12 (05)
  • [22] Beta-blockers in patients with advanced cirrhosis: Red light, green light, yellow light ...
    Peeraphatdit, Thoetchai
    Kamath, Patrick S.
    Shah, Vijay H.
    LIVER TRANSPLANTATION, 2017, 23 (06) : 725 - 726
  • [23] No value of non-selective beta-blockers after TIPS-insertion
    Tiede, Anja
    Stockhoff, Lena
    Rieland, Hannah
    Liu, Zhaoli
    Mauz, Jim B.
    Tergast, Tammo L.
    Kabelitz, Martin A.
    Schuette, Sarah S.
    Ehrenbauer, Alena F.
    Meyer, Bernhard C.
    Wedemeyer, Heiner
    Hinrichs, Jan B.
    Cornberg, Markus
    Falk, Christine S.
    Xu, Cheng-Jian
    Maasoumy, Benjamin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (08) : 1021 - 1032
  • [24] Using administrative healthcare data to evaluate drug repurposing opportunities for cancer: the possibility of using beta-blockers to treat breast cancer
    Tan, George S. Q.
    Botteri, Edoardo
    Wood, Stephen
    Sloan, Erica K.
    Ilomaki, Jenni
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [25] Non-selective beta-blockers increase overall and liver mortality in alcoholic cirrhosis with MELD ≥ 12 over 5 years of follow-up
    Cales, Paul
    Bertrais, Sandrine
    Boursier, Jerome
    Fouchard, Isabelle
    Oberti, Frederic
    LIVER INTERNATIONAL, 2021, 41 (01) : 168 - 179
  • [26] Effects of Beta-Blockers on Heart Failure with Preserved Ejection Fraction: A Meta-Analysis
    Liu, Feng
    Chen, Yanmei
    Feng, Xuguang
    Teng, Zhonghua
    Yuan, Ye
    Bin, Jianping
    PLOS ONE, 2014, 9 (03):
  • [27] Treatment of refractory ascites: Current strategies and new landscape of non-selective beta-blockers
    Gonzalez, David Vidal
    Lopez, Karla Paola Perez
    Nungaray, Sail Andre Vera
    Madrigal, Luis Guillermo Moreno
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45 (09): : 715 - 723
  • [28] When to stop non-selective beta-blockers: the window hypothesis in clinical practice Reply
    Krag, Aleksander
    Gluud, Lise Lotte
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2014, 23 (04) : 458 - 458
  • [29] Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control study
    Saad, Akram
    Goldstein, Jeffrey
    Margalit, Ofer
    Shacham-Shmueli, Einat
    Lawrence, Yaacov R.
    Yang, Yu-Xiao
    Reiss, Kim A.
    Golan, Talia
    Mamtani, Ronac
    Halpern, Naama
    Aderka, Dan
    Mouallem, Meir
    Goldstein, Adam
    Giantonio, Bruce
    Boursi, Ben
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (05) : 599 - 604
  • [30] Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy
    Ogata, Hitoko
    Ishikawa, Yuka
    Ishikawa, Yukitoshi
    Minami, Ryoji
    JOURNAL OF CARDIOLOGY, 2009, 53 (01) : 72 - 78
12345